logo
  • Kontakt
  • ENG
  • EE
  • Kontakt
  • ENG
  • EE
Avaleht Resources

Resources

    • MäRTS 9, 2025

    TBD Pharmatech at CDMO Live 2025 – Rotterdam

    We’re excited to announce that TBD Pharmatech will be attending CDMO Live 2025! When: 7 – 8 May 2025 (7 May: 08:00 – 18:00; 8 May: 08:00 – 16:00)Where: World Trade Center, Beursplein 37, Meent…

    Read more
    • haldur
    • Events
    • VEEBRUAR 23, 2025

    TBD Pharmatech at Pharma Contract Manufacturing 2025 – Berlin

    We’re excited to announce that TBD Pharmatech will be attending Pharma Contract Manufacturing 2025! 📅 When: 26 – 27 March 2025 Pharma IQ📍 Where: Mercure Hotel MOA Berlin, Stephanstraße 41,…

    Read more
    • haldur
    • Events
    • VEEBRUAR 1, 2025

    TBD Pharmatech at European Chemistry Partnering 2025 – Frankfurt

    We’re excited to announce that TBD Pharmatech will be attending European Chemistry Partnering 2025! 📅 When: 12 February 2025, 09:00 – 18:00 CET📍 Where: DECHEMA Society for Chemical Engineering…

    Read more
    • haldur
    • Events
    • JAANUAR 17, 2025

    Project: Small-molecule Novel Drug Ingredients Lab (RE.5.04.23-0268) – Preparative Flash Chromatography with an ELSD marks

    TBD Pharmatech’s recent addition of Preparative Flash Chromatography with an ELSD marks a significant enhancement in our “Small-molecule Novel Drug Ingredients Lab” project. This sophisticated…

    Read more
    • haldur
    • Science
    • AUGUST 28, 2024

    Project: Small-molecule Novel Drug Ingredients Lab (RE.5.04.23-0268) – 150L Jacketed Glass Reactor

    TBD Pharmatech’s recent procurement of 150L Jacketed glass reactor with thermostat, as part of the “Small-molecule Novel Drug Ingredients Lab” project, will add new capabilities to our organic…

    Read more
    • haldur
    • Science
    • APRILL 8, 2024

    TBD Pharmatech Production Building Cornerstone Event

    TBD Pharmatech laid the cornerstone for a new development and production building, which is part TBD Pharmatech’s development path and a contribution to Estonia’s knowledge-intensive entrepreneurship….

    Read more
    • haldur
    • TBD Pharmatech
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Categories

  • Rubriike pole

Archives

  • juuli 2025
  • mai 2025
  • aprill 2025
  • märts 2025
  • veebruar 2025
  • jaanuar 2025
  • august 2024
  • aprill 2024
  • veebruar 2024
  • jaanuar 2024
  • november 2023
  • september 2023
  • august 2023
  • juuli 2023
  • mai 2023
  • aprill 2023
  • märts 2023
  • veebruar 2023
  • jaanuar 2023
  • detsember 2022
  • november 2022
  • oktoober 2022
  • september 2022
    Ravimainete arendaja ja tootja, mis pakub peenkeemia lahendusi farmaatsia- ja biotehnoloogia ettevõttetele.

    Menu

    • Kontakt
    • ENG
    • EE

    Kontakt

    Project: Small-molecule Novel Drug…

    juuli 1, 2025

    TBD Pharmatech at CPHI…

    mai 29, 2025

    TBD Pharmatech at Nordic…

    mai 29, 2025

    TBD Pharmatech at BayOConnect…

    mai 14, 2025

    TDB Pharmatech at Chemspec…

    aprill 24, 2025

    TBD Pharmatech at Swiss…

    märts 13, 2025

    TBD Pharmatech at CDMO…

    märts 9, 2025

    TBD Pharmatech at Pharma…

    veebruar 23, 2025

    TBD Pharmatech at European…

    veebruar 1, 2025

    Project: Small-molecule Novel Drug…

    jaanuar 17, 2025

    Project: Small-molecule Novel Drug…

    august 28, 2024

    TBD Pharmatech Production Building…

    aprill 8, 2024

© 2025 TBD Pharmatech OÜ. All rights reservedPrivacy policyTerms and conditionsPowered by Häk
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}